Related Experiment Video
Updated: Sep 2, 2025

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Isolation and characterization of phage display-derived scFv antibodies against human parechovirus 1 VP0 protein
Eero Hietanen1, Lav Tripathi1, Eeva-Christine Brockmann2
1Institute of Biomedicine, University of Turku, Turku, Finland.
Abstract:
Human parechoviruses (PeVs) are common viruses that are associated with a variety of diseases from mild gastrointestinal and respiratory symptoms to severe central nervous system infections. Until now there has not been antibodies for visualizing parechovirus infection. We used E. coli recombinant PeV-A1-VP0 protein as a target in phage display single chain variable fragment (scFv) antibody library panning. Three rounds of panning allowed identification and isolation of several candidate scFv clones, which tested positive in enzyme-linked immunosorbent assay (ELISA) against VP0. Three scFv clones (scFv-55, -59 and -71) with different CDR-3 sequences were further purified and tested in ELISA, Western blot and immunofluorescence microscopy (IFA) against a set of PeV-A1 isolates and a few isolates representing PeV types 2-6. In IFA, all three scFv binders recognized twenty PeV-A1 isolates. ScFv-55 and -71 also recognized clinical representatives of PeV types 1-6 both in IFA and in capture ELISA, while scFv-59 only recognized PeV-A1, -A2 and -A6. PeV-A1-VP0 (Harris strain) sequence was used to generate a peptide library, which allowed identification of a putative unique conformational antibody epitope with fully conserved flanking regions and a more variable core VVTYDSKL, shared between the scFv antibodies. Sequencing of the VP0 region of virus samples and sequence comparisons against parechoviral sequences in GenBank revealed 107 PeV-A1, -A3, -A8, -A17, -A (untyped) sequences with this exact epitope core sequence, which was most dominant among PeV-A1 isolates. These data suggest the first-time isolation of broad range phage display antibodies against human parechoviruses that may be used in diagnostic antibody development.
Insights
Researchers developed novel phage display antibodies for detecting human parechoviruses (PeVs), common causes of various illnesses. These new antibodies show promise for advancing diagnostic tools for PeV infections.
Area of Science:
- Virology
- Immunology
- Biotechnology
Background:
- Human parechoviruses (PeVs) cause a spectrum of diseases, from mild symptoms to severe neurological infections.
- Currently, no specific antibodies exist for visualizing PeV infections, hindering diagnosis and research.
Purpose of the Study:
- To isolate and characterize novel single chain variable fragment (scFv) antibodies against human parechoviruses using phage display.
- To evaluate the diagnostic potential of these antibodies against various PeV types.
Main Methods:
- Phage display panning was employed using recombinant PeV-A1-VP0 protein as the target.
- Enzyme-linked immunosorbent assay (ELISA), Western blot, and immunofluorescence microscopy (IFA) were used to validate antibody binding.
- Peptide library generation and sequencing were performed to identify antibody epitopes.
Main Results:
- Three scFv clones (scFv-55, -59, -71) were successfully isolated and showed positive ELISA results against PeV-A1 VP0.
- ScFv-55 and -71 demonstrated broad reactivity against PeV-A1 isolates and recognized PeV types 1-6 in IFA and ELISA.
- A conserved epitope (VVTYDSKL) was identified, present in numerous PeV sequences, particularly PeV-A1.
Conclusions:
- The study reports the first isolation of broad-range phage display antibodies against human parechoviruses.
- These antibodies hold significant potential for the development of new diagnostic tools for PeV infections.

